YM 954
Latest Information Update: 24 Sep 1998
At a glance
- Originator Yamanouchi
- Class Nootropics
- Mechanism of Action Muscarinic M1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 24 Sep 1998 No-Development-Reported for Alzheimer's disease in Japan (Unknown route)